1 results match your criteria: "The Affiliated Hospital of Shanghai University of Chinese Traditional Medicine[Affiliation]"
Efficacy and Safety Analysis of Recombinant Human Endostatin (Endostar) Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer: A 2-Center Retrospective Study.
Technol Cancer Res Treat
July 2024
Department of Radiotherapy, ShuGuang Hospital, The Affiliated Hospital of Shanghai University of Chinese Traditional Medicine, Shanghai, China.
Background: This study aims to assess the efficacy and safety of Endostar in the management of locally advanced cervical cancer.
Methods: This retrospective, 2-center study enrolled 41 patients with locally advanced cervical cancer between June 2017 and December 2020. The patients were subjected to a combination of Endostar and chemoradiotherapy until they experienced disease progression or an unacceptable level of toxicity.